ArticleBMC immunology2026

Cetuximab combination with cytokine induced killer cells effectively inhibit conjunctival squamous cell carcinoma in vitro.

Hossein Aghaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.